PALISADE BIO, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Palisade Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Palisade Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $29M, a 8.54% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $29M +$2.28M +8.54% Dec 31, 2023 10-K 2024-03-26
Q4 2022 $26.7M +$3.85M +16.9% Dec 31, 2022 10-K 2024-03-26
Q4 2021 $22.8M +$12.8M +128% Dec 31, 2021 10-K 2023-03-22
Q4 2020 $10M -$36.7M -78.5% Dec 31, 2020 10-K 2022-03-17
Q4 2019 $46.7M +$456K +0.99% Dec 31, 2019 10-K 2021-03-22
Q4 2018 $46.2M +$2.74M +6.3% Dec 31, 2018 10-K 2020-03-27
Q4 2017 $43.5M -$19.3M -30.7% Dec 31, 2017 10-K 2019-03-22
Q4 2016 $62.7M +$6.81M +12.2% Dec 31, 2016 10-K 2018-04-02
Q4 2015 $55.9M +$7.6M +15.7% Dec 31, 2015 10-K 2017-03-23
Q4 2014 $48.3M +$5.63M +13.2% Dec 31, 2014 10-K 2016-03-14
Q4 2013 $42.7M +$3.93M +10.1% Dec 31, 2013 10-K 2015-03-16
Q4 2012 $38.8M +$4.04M +11.6% Dec 31, 2012 10-K 2014-03-10
Q4 2011 $34.7M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.